Lupus (SLE) trials in New Zealand
1 trial · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
- Where
- Auckland
- Age
- 18 years to 75 years
- People
- 62 worldwide
- Run by
- Sanofi
See details and how to joinNCT06647069